Download Curriculum Vitae

Dr. Courtney is originally from New Hampshire. He initially was drawn to cancer research as an undergraduate at Dartmouth College, where he studied chromium carcinogenesis in the laboratory of Dr. Karen Wetterhahn. He received his M.D. and his Ph.D. in molecular cancer biology from Duke University through the Medical Scientist Training Program. After completing his residency training in Internal Medicine at the University of California, San Francisco, Dr. Courtney completed his medical oncology fellowship at the Dana-Farber Cancer Institute / Dana-Farber Harvard Cancer Center. There he pursued post-doctoral studies in signal transduction and cancer metabolism in the laboratory of Dr. Lewis Cantley. Following his fellowship, Dr. Courtney continued on as faculty at Harvard Medical School and as an attending oncologist at Dana-Farber in the Lank Center for Genitourinary Oncology.

Dr. Courtney joined the faculty at UT Southwestern in 2012. He specializes in genitourinary malignancies, with an emphasis on prostate and kidney cancer. Dr. Courtney's research efforts are focused on developing investigator-initiated clinical trials in prostate and kidney cancer that draw on his background in laboratory research and through collaborations with the outstanding basic scientists at UTSW.


Other Post Graduate Training
Duke University School of Medicine (2001)
Graduate School
Duke University School of Medicine (2001)
Medical School
Duke University School of Medicine (2002)
University of California, San Francisco (2005), Internal Medicine
Dana-Farber Cancer Institute (2008), Oncology

Research Interest

  • Clinical-translational research in genitourinary oncology
  • Industry- and cooperative group-sponsored trials in genitourinary malignancies
  • Investigator-initiated clinical trials in kidney cancer
  • Investigator-initiated clinical trials in prostate cancer
  • Novel biomarkers and therapeutics in prostate and kidney cancer


Featured Publications LegendFeatured Publications

The Abl interactor proteins localized to sites of actin polymerization at the tips of lamellipodia and filopodia
Stradal T, Courtney KD, Rottner K, Hahne P, Small JV, Pendergast AM Current Biology 2001 11 891-5
Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system
Courtney KD, Grove M, Vandongen H, Vandongen A, LaMantia A-S, Pendergast AM Molecular and Cellular Neuroscience 2000 16 244-57
Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases.
Quackenbush RC, Reuther GW, Miller JP, Courtney KD, Pear WS, and Pendergast AM. Blood 2000 95 2913-21
Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway
Dai Z, Quackenbush RC, Courtney KD, Grove M, Cortez D, Reuther GW, Pendergast AM Genes and Development 1998 12 1415-24
Reduction of chromium (VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
Stearns DM, Kennedy LJ, Courtney KD, Giangrande PH, Pheiffer LS, and Wetterhahn KE. Biochemistry 1995 34
Chromium (VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro.
Stearns DM, Courtney KD, Giangrande PH, Phieffer LS, and Wetterhahn KE Environmental Health Perspectives 1994 102


Featured Books Legend Featured Books

Honors & Awards

  • John W. Boddie, Ph.D. & Joan Reisch, Ph.D. Fund in Prostate Cancer Research in Honor of Dr. Kevin Courtney
  • Wheels for Wellness Classic Hero Award of Gratitude from the Wheels for Wellness Foundation and Moncrief Cancer Institute
  • UT Southwestern Golden Pager Award
  • Career Development Award
    Genentech, Inc. Dana-Farber/Partners Cancer Center (2008)
  • Young Investigator Award
    American Society of Clinical Oncology (2008)
  • Sigma Xi
    Member (1993)
  • Phi Beta Kappa
    Membership (1992)

Professional Associations/Affiliations

  • American Society of Clinical Oncology (2008)